Cui et al. (19) have confirmed that pathological cardiac hypertrophy could be alleviated by reducing oxidation, inflammation, and apoptosis induced by AngII via Sirt1-mediated activation of AMPK/PGC1α signal molecules. Here, PPARGC1A is linked to cardiac hypertrophy.